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Abstract.  Immunocytochemical  localization  of throm- 
bospondin  (TSP),  a  trimeric  glycoprotein constituent 
of extracellular  matrices,  produced  striking  regional 
and temporal patterns  of distribution  in the developing 
mouse embryo. TSP was present  in many basement 
membranes,  surrounded  epithelial  cells,  and was as- 
sociated with peripheral  nerve outgrowth.  During or- 
ganogenesis,  TSP was also found on the surface of 
myoblasts and chondroblasts,  and TSP was differen- 
tially deposited in cortical  layers.  With differentiation 
of chondrocytes and myotubes immunoreactivity  was 
decreased,  and differential  cortical  staining  was lost. 
Presence of TSP was associated with morphogenetic 
processes of proliferation,  migration,  and  intercellular 
adhesion. 
C 
ELL migrations, cell-cell interactions, and, ultimately, 
cellular  differentiation  are directed in development 
by both genetic and epigenetic phenomena.  Of the 
latter, the extracellular matrix (ECM) m  (which is composed 
of tissue-specific proportions  of collagens,  proteoglycans, 
glycosaminoglycans, glycoproteins, water, and ions) appears 
to be of critical importance.  In the current investigation, we 
have examined the deposition of a unique ECM component, 
thrombospondin  (TSP),  during  the  development  of  the 
mouse embryo. 
TSP  is  a  large  glycoprotein (Mr  420,000)  composed of 
three  identical  subunits  in  disulfide  linkage  (Dixit  et  al., 
1984; Lawler et al.,  1985). TSP was originally described as 
a platelet alpha granule component (Baenzinger et al.,  1971) 
which was released on activation and became associated with 
the platelet surface to mediate platelet aggregation (Dixit et 
al., 1985). TSP is synthesized by a number of additional cells 
including  smooth muscle (Raugi et al.,  1982), endothelial 
cells (Mosher et al.,  1982),  keratinocytes  (Wikner et al., 
1987), macrophages  (Jaffe et al.,  1985), glia (Asch et al., 
1986), and fibroblasts (Raugi et al., 1982). Like other large, 
adhesive glycoproteins, TSP may serve as an attachment fac- 
tor for a variety of cells (Varani  et al.,  1986; Roberts et al., 
1987).  It appears to control proliferation and migration  of 
smooth muscle cells (Majack et al., 1986) as well as chemo- 
taxis of melanoma cells (Taraboldi et al.,  1987). 
TSP's widespread  synthesis,  its  role  in adhesion  and in 
control of proliferation, as well as its rapid incorporation into 
and removal from the ECM,  suggest that TSP may play an 
important role in regulating the structure of the extracellular 
milieu,  and,  thus,  influence development.  The current  re- 
1. Abbreviations used in this paper: CNS, central nervous system; ECM, 
extracellular matrix; TSP,  thrombospondin. 
port describes striking alterations in the distribution of TSP 
during the development of the mouse embryo. 
Materials and Methods 
Tissue 
Embryos were isolated from matings of CD-I  strain mice on days 9-17 of 
gestation (first day  =  + vaginal plug; gestation period  =  19 d).  Selected 
additional tissues from neonatal (postnatal day 10) or from adult mice were 
also examined. Because of the inherent difficulties in working with fresh 
frozen sections and for EM studies, numerous fixation protocols have been 
carried  out  in an attempt to  improve tissue preservation and  retain im- 
munoreactivity. These protocols include fixation in: 10% formalin; 2 or 4 % 
paraformaldehyde with and without 0.1-0.2%  glutaraldehyde; phosphate, 
Tris, or cacodylate buffer; or by using the AMeX method (acetone fix at 
-20°C  overnight;  see Sato  et  al.,  1986).  Fixation periods varied  from 
30-120 rain, and were followed by sodium borohydride (0.1%) treatment of 
whole embryos (or sections), and embedment in either OCT, paraffin, poly- 
ester wax (Kusakabe et al.,  1984), or polyethylene glycol (water soluble). 
Because there was decreased anti-TSP immunoreactivity with any chemical 
fixative, the light microscopical results are based on sections of unfixed, fro- 
zen tissue. 
Whole unfixed embryos and adult tissue were rapidly frozen in OCT 
embedding compound (Miles  Laboratories  Inc.,  Elkhart,  IN)  in hexane 
cooled over an acetone-dry ice slurry. Blocks were stored at -70°C before 
sectioning. Sagittal and transverse sections were cut at 8 p.m and collected 
on  0.1%  poly-L-lysine (molecular  weight  greater  than  300,000)  coated 
slides. At least 10 embryos at each developmental stage from a total of 128 
were examined in the course of this study. 
Immunocytochemistry 
Selected sections were washed in PBS, and tissue was exposed to normal 
goat serum (1:20),  followed by the primary antibody (TSP 1:20; type IV col- 
lagen 1:100) for 2  h at room temperature. Controls were exposed to PBS 
or to rabbit serum in place of the primary antibody. For preabsorption con- 
trois, sections were treated with a  1:20 dilution of antiserum that had been 
incubated previously with excess TSP in a proportion equivalent to 10 I-tg 
of purified TSP per 1 lag of rabbit anti-TSP IgG. All sections were subjected 
to similar rinses and incubation periods. 
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anti-rabbit IgG conjugated to FITC (1:50),  for 30 min at room temperature, 
and then washed thoroughly in PBS. Slides were coverslipped with glycerol 
containing 0.1% phenylenediamine and sealed. Sections were photographed 
in a  Dialux Orthoplan photomicroscope (E.  Leitz, Inc.,  Rockleigh, NJ) 
using Kodak Recording 2475  or Tri-X Pan film. 
Because of the many interactions between ECM components, a number 
of pretreatments were used to augment the intensity of anti-TSP staining or 
to "restore" antigenicity to fixed tissue. Pretreatment of sections with testicu- 
lar hyaluronidase (400 IU/ml for 1 h at 37°C)-but not with Streptomyces 
hyaluronidase (100 TRU/ml) nor collagenase (275 IU/ml, pH 7.4)-before 
exposure to the primary antibody, resulted in the altered patterns of staining 
for TSP described below,  but no treatment augmented staining intensity. 
For electron microscopic localization of TSP, tissue was briefly fixed in 
2% paraformaldehyde and 0.1% glutaraldehyde in 0.1 M phosphate buffer 
for 45 min at room temperature. It was then vibratome sectioned in agar 
(13%)  at 50 Ixm, and slices were washed and stored in 0.1  M phosphate 
buffer before staining. Slices were preincubated in 5% normal goat serum 
in PBS also containing 2% BSA for 2 h at room temperature and rinsed in 
PBS with 1% BSA. Slices were next exposed to the primary antibody made 
up in PBS with 1% BSA for 15 min at room temperature and then at 4°C 
overnight. Tissue was rinsed; fixed in 1.5% glutaraldehyde in 0.1 M caco- 
dylate buffer (pH 7.4) with 5 % sucrose for 1 h at room temperature; and 
then rinsed in 0.1 M cacodylate buffer followed by an additional rinse in 50 
mM  Tris-HCl  buffer (pH  7.4).  Slices were then incubated in 0.1%  di- 
aminobenzadine with 0.01% hydrogen peroxide in 50 mM Tris-HCl buffer 
for 10 min. After an additional rinse, slices were stained in  1% osmium 
tetroxide and 1% potassium ferrocyanide in 0.1 M cacodylate buffer for 45 
min at 4°C. Slices were rinsed, dehydrated through graded alcohols, embed- 
ded in Araldite resin, sectioned, viewed, and photographed in an electron 
microscope (model 400;  Philips Electronic Instruments, Inc.,  Mahwah, 
NJ). For EM localization, anti-TSP was used at 1:10 and antibodies to the 
glial fibrillary acidic protein were used at 1:50. Additional controls were ex- 
posed either to normal rabbit serum diluted 1:50 or to PBS alone. 
Antibodies 
Rabbit polyclonal antibody to TSP was obtained and characterized as de- 
scribed previously (Roberts et al., 1985; Varani et al., 1986). Briefly, rabbit 
antisera was raised to human platelet TSP and the IgG fraction purified on 
a  protein A-Sepharose column (Bio-Rad Laboratories,  Richmond, CA). 
The antibody, as assayed by radioimmunoassay (Dixit et al., 1985) and im- 
munoprecipitation of metabolically labeled human carcinoma cells (Varni 
et al.,  1986),  was specific for TSP. Antibody to type IV collagen was pur- 
chased from Dr. H. Furthmayr (Yale University), was affinity purified and 
exhibited no cross-reactivity to other ECM components when examined 
using ELISA. Antibody to the glial fibrillary acidic protein was purchased 
from Dakopatts (Copenhagen). 
Cell Culture 
Mouse NIH 3T3 cells were maintained in DME supplemented with 10% 
FCS,  penicillin (100  U/ml),  and  streptomycin (100  Ixg/ml).  All culture 
materials were purchased from Gibco Laboratories (Grand Island, NY). 
Biosynthetic Labeling and Immunoprecipitation 
Mouse NIH 3T3 cells were grown in 100-ram culture dishes to an approxi- 
mate density of 2  x  106 cells/dish. The cells were washed twice in serum- 
free DME without cysteine and methionine and were incubated overnight 
in the same medium supplemented with 10% dialyzed FCS, 100 gCi/ml of 
[35S]methionine  (1,000-1,400  gCi/I.tM;  New  England  Nuclear,  Boston, 
MA) and  1130 gCi/ml of [35S]cysteine (937  Ci/mmol; New England Nu- 
clear). Metabolic labeling with both [35S]methionine and [35S]cysteine was 
done in order to minimize any bias in labeling of proteins that may be 
deficient in one or the other amino acid. 
The medium was removed and the cells lysed in a solution of PBS that 
contained detergents (1%  Triton X-100,  0.5%  sodium deoxycholate, and 
0.1% SDS; Sigma Chemical Co., St. Louis, MO) and protease inhibitors 
including 20 mM EDTA, 5 mM N-ethylmaleimide, and 2 mM PMSE The 
labeled medium was also supplemented with the detergent/protease inhibi- 
tor mixture by adding 0.25 vol of a fivefoid concentrated solution. The la- 
beled cell lysates and media were mixed and clarified by ultracentrifugation 
(37,000 g  for 60 min). 
Immunoreactive TSP was precipitated with a 1:100 dilution of the rabbit 
anti-TSP and protein A-Sepharose (Pharmacia, Uppsala, Sweden) as de- 
scribed previously (Dixit et al.,  1985).  Affinity-purified rabbit anti-mouse 
IgG served as a control. Washed immunoprecipitates were eluted by boiling 
(5 min) in Laemmli SDS-PAGE sample buffer with 2 % 2-mercaptoethanol 
and resolved on a 4-12% gradient Laemmli polyacrylamide gel (Dixit et 
al.,  1985).  Radiolabeled proteins were visualized by fluorography with 
EN3HANCE (New England Nuclear). 
Tissue lmmunoblotting 
Day-13 embryos were homogenized with a Polytron tissue homogenizer in 
Laemmli SDS-PAGE sample buffer.  Soluble proteins were resolved on a 
7.5%  Laemmli polyacrylamide gel and electrophoretically transferred to 
nitrocellulose paper.  Nonspecific binding was blocked by incubating the 
blots with 3 % BSA for 2 h at room temperature. 
The blots were next incubated with either rabbit anti-TSP (MOO) or con- 
trol antibody (rabbit anti-mouse IgG) in 0.02 M Tris HCI, pH 7.5; 0.5 M 
NaC1;  1% BSA for 1 h at room temperature. Transfers were rinsed twice 
with the above buffer containing 0.05%  Tween 20 and then incubated with 
horseradish pemxidase-conjugated goat anti-mouse IgG for 2  h at room 
temperature. After several washes with the Tween-containing  buffer, peroxi- 
dase activity was detected with 4-chloronaphthol and hydrogen peroxide. 
Results 
Antibody Specificity 
The rabbit anti-TSP antibody used in these studies has been 
previously shown to be specific for human  TSP because it 
will specifically and quantitatively  immunoprecipitate TSP 
from [35S]methionine-labeled  human  squamous carcinoma 
cells (Varani et al., 1986).  To ensure specificity of the anti- 
body for mouse TSE we metabolically labeled mouse NIH 
3T3  cells with  [35S]methionine  and  [35S]cysteine  and  sub- 
jected total labeled proteins (both media and cell lysate)  to 
immunoprecipitation. 
As illustrated  in Fig.  1, the rabbit anti-TSP antibody  (lane 
3), unlike a control antibody (lane 4), specifically immuno- 
precipitated  a protein that comigrates with an iodinated TSP 
marker (lane/). Even after prolonged exposure of the autora- 
diogram, TSP was the only protein immunoprecipitated by 
the rabbit anti-TSP antibody. 
To further ensure the specificity of the antibody used in 
these studies, a tissue immunoblotting was carried out (Fig. 
2). Soluble protein extract from day-13 mouse embryos was 
resolved by  SDS-PAGE,  transferred  to nitrocellulose,  and 
reacted  with rabbit anti-TSP or control antibody.  As shown 
in Fig. 2, rabbit anti-TSP detected a protein in embryonic tis- 
sue extracts  (lane 4) that comigrated with purified human 
platelet TSP (lane 6). Control antibody showed no reactivity 
to either (lanes  7 and  9). 
Imraunocytochemistry 
Immunocytochemical results are presented according to de- 
velopmental stage:  (a) neurulation (days 9-11);  (b) organo- 
genesis (days 13,  15); and (c) fetal period (day 17). No im- 
munoreactivity was observed in tissues exposed to PBS in 
place of the primary antibody nor with preabsorption con- 
trois. When normal rabbit serum replaced the primary anti- 
body, there was slight staining only of the forming perichon- 
drium (Fig. 3 f). This pattern was observed on each day of 
development examined. The contribution of platelet TSP to 
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cells were metabolically labeled with [35S]cysteine and [3SS]methi- 
onine and total labeled proteins (lane 2) were immunoprecipitated 
either  with rabbit anti-TSP (lane 3) or control antibody (lane 4). 
Arrow indicates the position  of migration of an iodinated human 
platelet  TSP  standard  (lane  /).  Proteins  were  resolved  by SDS- 
PAGE on a 4-12 % gradient Laemmli gel and visualized by autoradi- 
ography.  Kodak  X-OMAT  AR  film  was  exposed  overnight  at 
-80°C. 
staining was negligible because of the paucity of platelets in 
early embryos. 
Neurulation (Days 9-11). During this period, mouse em- 
bryos develop from 5  to 38 somites, the embryo rotates to 
adopt the fetal position, and the heart tube forms (Fig. 3, a 
and b).  During this period,  TSP was present in basement 
membranes of the  surface ectoderm  and  neuroepithelium 
(Fig. 4 a) and was densely deposited between neuroepithelial 
cells (Fig. 3, a and b; Fig. 4, a and b). TSP was particularly 
densely deposited in the neural crest migratory pathway at 
the dorsolateral surface of the neuroepithelium. With aggre- 
gation of neural crest to form ganglia, TSP was present on 
the surface of aggregating cells (Fig. 4 a). At the later phases 
of this stage, TSP outlined processes emerging from the ven- 
tral neuroepithelium (Fig. 4  b). 
TSP was found in the epimyocardium and epicardium of 
the heart (Fig. 4, c and d) but was not yet a component of 
the endocardium or of forming blood vessels (Fig. 3, a  and 
b). TSP was also found in forming somites, especially in the 
outer, epithelial portions (Fig. 4 e). In the liver by the  10th 
day of development, a  regional population of cells was in- 
tensely stained (Fig. 4 f). 
When sections were pretreated with testicular hyaluroni- 
dase, the pattern of immunoreactivity was altered. In the de- 
veloping optic vesicle for example, TSP was present between 
neuroepithelial  cells  and  in  the  neuroepithelial  basement 
membrane (Fig.  4  g).  After testicular hyaluronidase treat- 
ment, staining was present in the basement membrane, but 
not within the neuroepithelium itself (Fig. 4  h). 
Organogenesis (Days 13, 15). During organogenesis, TSP 
was a less general component of the developing embryo, be- 
coming associated more clearly with  specific cell popula- 
tions (Fig.  3,  c  and d). 
Figure 2.  Specificity of rabbit anti-TSP 
shown by tissue immunoblotting. Solubi- 
lized 13-d mouse embryo extract (lanes 
1,  4,  and  7)  and  purified  human  TSP 
(lanes  3,  6,  and  9)  were  resolved  by 
SDS-PAGE and transferred to nitrocellu- 
lose paper. Lanes 2, 5, and 8 were left 
blank to ensure no "spill-over" of mate- 
rial  between  lanes.  Lanes  1-3  were 
stained for protein (Amido black); lanes 
4-6 were  allowed to react  with  rabbit 
anti-TSP; lanes 7-9 were allowed to re- 
act with control antibody. Immune com- 
plexes  were  visualized  by  incubation 
with horseradish peroxidase-conjugated 
goat  anti-mouse IgG.  Molecular  mass 
markers in kilodaltons are shown (lejq). 
O'Shea and Dixit Thrombospondin in Development  2739 Figure  3.  Sagittal sections through embryos isolated on days 10-17 of gestation illustrating the pattern of deposition of TSP (a-e), and 
lack of immunoreactivity in a control embryo (/). Embryos are oriented with their cephalic region toward the top of the micrographs and 
their dorsal surface toward the right. (a) Sagittal section through a day-10 embryo. TSP was densely deposited in the forming CNS and 
heart. M, midbrain; h, heart; AlE, neuroepithelium. Bar, 100 Ixm. (b) Day-ll embryo illustrating  the dense deposition of TSP in the forebrain 
(F), hindbrain (/at), and spinal cord (arrow) at this stage of development. M, midbrain. Bar, 500/am. (c) Day-13 embryo illustrating pattern 
of deposition of TSP in the CNS and developing heart (h), in forming liver (L), and in gut (arrow),  sc, forming spinal cord. Bar,  1 mm. 
(d) On day 15 TSP was present in the CNS, in forming cartilage (arrows),  and in skeletal muscle (S). Scattered hepatic cells stained strongly 
for TSP as did salivary gland, forming bronchi in the lung and herniated gut. The vertical "line" coursing through the liver (L) is a fold 
in the tissue. Bar,  1 mm. (e) Sagittal section through a day-17 embryo. TSP was present in many basement membranes, in the heart (h), 
skin, perichondrium, and gut (arrow).  Although present, it was a less prominent component of the CNS and ofchondrocytes than at previous 
stages, sc, spinal cord. Bar,  1 mm. (f) Day-15 control embryo incubated in normal rabbit serum rather than anti-TSP IgG illustrating the 
general lack of immunofluorescence. Light perichondrial stain was observed with normal rabbit serum that was not present in preabsorption 
or in PBS controls. Similar results were obtained at each developmental stage examined. Bar,  1 mm. 
Figure 4.  Survey of TSP localization in several organs at the earliest stages of development examined (days 9-11).  (a) Transverse section 
through the region of crest cell migration from the neuroepithelium (NE) late on day 9 of development. Note the dense deposition of TSP 
between neuroepithelial cells, in the migration zone and in the neuroepithelial basement membrane (arrow).  Bar, 100 ~tm. (b) Transverse 
section through the neuroepithelium in a day-10 embryo, illustrating the deposition of TSP between neuroepithelial cells (NE). It was also 
particularly densely deposited in the ventral root pathway (arrow).  Bar,  100 Ixm. (c) Sagittal section through the developing heart tube 
illustrating the dense deposition of TSP in the epimyocardium and epicardium, but little staining in the forming endocardium on the 10th 
day. Bar, 100 p.m. (d) Higher magnification of the wall of the heart tube illustrating TSP deposition in the epimyocardium (e) and forming 
epicardium (ep). Bar, 50 ktm. (e) Sagittal section through two adjacent somites (S) from the spinal region late on day 9 of development. 
TSP was particularly densely deposited between cells in the outer epithelial layer (arrow),  compared to the core of the somites (sclerotome). Bar, 50 p.m. (f) Unlike later stages of development, a large proportion of cells in the liver (L) stained intensely for 'ISI?  on day 11 of gestation. 
Bar, 100 Ixm. (g) On day 10, TSP was densely deposited in the neuroepithelium (NE) and basement membrane (arrow) of the optic vesicle 
(ov). Bar, 100 gtm. (h) Sequential section through the optic vesicle (ov) pretreated with testicular hyaluronidase before localization of TSP. 
TSP was present in the basement membrane (arrow) but was no longer demonstrable between neuroepithelial cells (NE).  Bar,  100 gtm. The Journal of Cell Biology, Volume  107, 1988  2742 On the 13th day, TSP continued to surround neuroepithe- 
lial cells and was present in the neuroepithelial basement 
membrane at the pial surface (Fig. 5, a and b). In the cortex, 
TSP was differentially deposited in the developing cortical 
layers. The cortical plate and forming glial endfeet regions 
stained particularly densely (Fig. 5, a and b). Ganglia (ceph- 
alic, dorsal root, and autonomic) also contained dense de- 
posits of TSP (Fig. 5, c and d), and nerve rootlets emerging 
from dorsal root ganglia were intensely stained. TSP was 
present in the epicardium and forming myoepicardium as 
well as in the endocardium of the heart (Fig. 5, e and  f). TSP 
was present in a subset of liver cells (Fig. 5, g and h) and 
outlined the basement membrane of the forming bronchi in 
the lung. 
By day 15, the population of presumably hematopoietic 
ceils present in the liver continued to stain and now were 
diffusely distributed rather than forming clusters (Fig. 3 d). 
In the central nervous system (CNS), TSP surrounded neu- 
roepithelial cells (Fig. 6, a  and b) and was deposited at the 
pial surface and near the lumen. In the cerebellar anlagen 
near the fourth ventricle, radial deposits of TSP extended 
from the rhombic lip across the developing cerebellum. In 
the lung, salivary gland, and kidney, TSP was found between 
cells and particularly in basement membranes (Fig. 6, c and 
d). On day 15, undifferentiated myoblasts contained consid- 
erable TSP on their surfaces (Fig. 6, e and f) as did chon- 
droblasts (Fig. 6, g and h). As chondrocytes hypertrophied, 
beginning on the 15th day, the deposition of TSP on their sur- 
faces was reduced (Fig. 6, g and h). 
Early Fetal Development (Day 17). During later phases 
of development,  the  pattern  of TSP  deposition remained 
somewhat similar to that seen on days 13 and 15 with impor- 
tant exceptions (Fig. 3 e). In the nervous system, although 
less prominently than at earlier stages, TSP continued to sur- 
round neuroepithelial cells but without the obvious layering 
observed earlier (Fig.  7,  a  and b).  By day 17,  the radial 
deposits observed in the cerebellar cortex on day 15 were no 
longer present, but TSP was densely deposited  just below the 
pial surface. Growing peripheral nerve continued to stain 
strongly for TSP. 
By the 17th day, there was a reduction in the proportion 
of hepatic cells that were stained. TSP remained present in 
epithelia and their basement membranes in lung (Fig. 7, c 
and d), salivary gland, and colonic epithelium. By the 17th 
day, endothelial cells lining larger vessels (Fig. 7, c and d) 
were stained as was the choroid plexus of the fourth ventri- 
cle. As myoblasts that had contained considerable TSP on 
their surfaces fused to form multinucleate myotubes, TSP 
was much less prominent on their surfaces (Fig. 7, e and f). 
In the skin, TSP was distributed between cells and was pres- 
ent in the basement membrane at the forming dermal epider- 
mal junction (Fig. 7, g and h) and at developing hair follicles 
and vibrissae. 
In an attempt to further characterize the presence of TSP 
in basement membranes, we examined a  number of addi- 
tional  tissues  from older  animals  including lung,  ovary, 
placenta, nerve, brain, and liver. When examined at the light 
level, TSP was present in basement membranes of epithelial 
cells from these organs, and often TSP was found in associa- 
tion with lateral cell surfaces as well. For example, the base- 
ment membrane separating granulosa and theca interna cells 
in developing ovarian follicles contained considerable TSP 
with slight cell surface stain (Fig. 8 a). By comparison, type 
IV  collagen was  more  clearly restricted to the basement 
membrane (Fig. 8 b). 
At the electron microscopic level, TSP was clearly depos- 
ited in basal laminae (see Fig. 8 c, for example in a capil- 
lary endothelial cell). Neither localization of an "irrelevant 
antibody" normal rabbit serum, nor replacement of the pri- 
mary antibody with PBS revealed any basal lamina reactiv- 
ity. Localization of antibodies to the glial fibrillary acidic 
protein resulted in restriction of reaction product to astro- 
cytic cytoplasm in the cerebeUar cortex (Fig. 8 d). 
Discussion 
This is the first report of the striking regional and temporal 
patterns of TSP deposition during development. Although a 
comprehensive discussion of the role of TSP in the morpho- 
genesis of the individual tissues is clearly beyond the scope 
of the current investigation, several broad patterns emerge. 
At the earliest stages examined, TSP was densely depos- 
ited between neuroepithelial cells as the neural folds elevat- 
ed, met, and fused in the dorsal midline of the embryo. TSP 
was present in basement membranes and was less densely 
deposited in the mesenchyme although TSP surrounded neu- 
ral crest cells as they migrated and also as they aggregated 
to form ganglia. This pattern has not previously been report- 
ed during early development since laminin, fibronectin, type 
IV  collagen,  heparan  sulfate  proteoglycan  (Tucker  and 
Morriss-Kay,  1986;  Sternberg and Kimber,  1986;  O'Shea, 
1987) are present in neuroepithelial basement membranes; 
fibronectin and heparan sulfate proteoglycan (Sternberg and 
Kimber,  1986;  O'Shea,  1987) are additional mesenchymal 
components. Presence of TSP on neuroepithelial cells at this 
stage parallels only the deposition of the neural cell adhesion 
molecule (Thiery et al., 1982) and of  the fibronectin receptor 
(Duband et al., 1986)-but not of fibronectin itself-in avian 
embryos.  Localization of the  cell  substratum  attachment 
(CSAT) receptor complex is similar to TSP in that it sur- 
rounds neuroepithelial cells, neural crest, and dorsal root 
ganglia, and is found in basement membranes as well (Kro- 
toski et al.,  1986). 
In the peripheral nervous system at all stages examined, 
TSP was associated with outgrowing nerve processes. Lami- 
nin has a distribution similar to TSP during early outgrowth 
Figure 5. Sagittal  sections of several tissues from day-13 embryos, a, c, e, and g illustrate depositional  patterns of  TSE b, d,f, and h represent 
the corresponding phase-contrast micrographs. (a and b) Cerebral cortex and pial surface (p) illustrating the deposition of TSP on neu- 
roepithelial cell surfaces and in the forming pia mater. TSP was also particularly densely deposited at this stage in the cortical plate region 
(brackets). L, lumen of the neural tube. (c and d) Grazing sagittal section illustrating nerve roots (arrow)  and associated dorsal root ganglia 
(G). (e and f) Section through a portion of the heart tube illustrating TSP deposition in the forming myocardium  and in the endocardium 
(arrow) at this stage of development. (g and h) A subset of hepatic cells continued to stain intensely for TSP. Bars, 100 p.m. 
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1/NC-1 is similarly found in the ventral horn in the region 
of motor neuron axon outgrowth (Tucker et al.,  1988).  In 
later consolidation of the nerve,  however,  the patterns are 
considerably different. The presence of TSP on both migrat- 
ing and aggregating neural crest cells is also unparalleled by 
other ECM components. Fibronectin, for example, is pres- 
ent during neural crest cell migration but is largely displaced 
from between crest cells as they aggregate to form ganglion 
rudiments (Duband et al.,  1985). 
Presence of TSP  in regions of cell migration and rear- 
rangement may be associated with its ability to bind both 
plasminogen and tissue plasminogen activator. This binding 
greatly enhances plasminogen activation by tissue plasmino- 
gen activator (Silverstein et al., 1984,  1985, 1986). It is pos- 
sible that TSP may form a nidus for protease generation dur- 
ing cellular migrations and tissue remodeling critical in early 
development. Although the distribution of tissue plasmino- 
gen activator during early embryogenesis has not been pre- 
cisely determined, tissue plasminogen activator is similarly 
present  during  granule  cell  migration  in  the  cerebellum 
(Krystosek and Seeds, 1981), during neurite outgrowth (Pat- 
terson, 1985), and in the development of the peripheral ner- 
vous system (Baron-VanEvercooren  et al.,  1987). 
TSP was densely deposited in many basement membranes 
including neuroepithelial; surface ectodermal (later in the 
dermal epidermal junction,  see also Wight et al.,  1985); 
of salivary gland; gut;  kidney; and lung;  in ovarian folli- 
cles. In certain of these regions, TSP was deposited in as- 
sociation with regions of branching like other ECM com- 
ponents (e.g., Bernfield et al., 1984).  However, unlike other 
matrix components TSP was also present between epithelial 
cells as the basement membrane formed. Testicular hyal- 
uronidase sensitivity of cell surface, but not basement mem- 
brane, TSP suggests that TSP present in the basement mem- 
brane may associate not only with glycosaminoglycans but 
also with other ECM components, which decrease its sus- 
ceptibility to being released by hyaluronidase treatment. 
TSP is capable of binding a  number of ligands: glycos- 
aminoglycans (Dixit  et  al,,  1984;  Lawler et  al.,  1985), 
fibronectin (Lahav et al., 1982,  1984), plasminogen (Silver- 
stein et al., 1984), laminin (Mumby et al., 1984), types I and 
V collagen (Lahav et al.,  1982;  Mumby et al.,  1984).  Be- 
cause of the affinity of TSP for many ECM components and 
its rapid removal from and incorporation into the ECM via 
its heparan binding domain (McKeown-Longo et al., 1984), 
TSP may play an important role in determining the structural 
characteristics of the matrix associated with these tissues. 
Somewhat surprisingly, there  was  little TSP  present  in 
early forming blood vessels, unlike laminin and type IV col- 
lagen which are present very early in the forming basement 
membrane of these vessels (O'Shea,  1987).  At later stages 
of development, TSP was clearly present in endothelial cells 
as well as in the endocardium. It will be interesting to deter- 
mine whether or not TSP becomes associated with smooth 
muscle cells of the vessel wall with the significant pressure 
alterations at birth. 
Interestingly, TSP immunoreactivity present on the sur- 
face both of chondroblasts (see also Miller and McDevitt, 
1988)  and  myoblasts was  decreased  with  differentiation. 
Whether the presence of TSP (a) is associated with cellular 
proliferation, as in other systems (Majack et al.,  1986),  or 
(b) plays a role in controlling cell-cell interactions remains 
to  be  determined.  It  will  be  interesting to  examine the 
detailed pattern of deposition within the sclerotome during 
earlier development and to determine the pattern of deposi- 
tion in mature skeletal muscle. 
Not  surprisingly,  TSP  is  associated  with  several  very 
different morphogenetic processes, including cellular migra- 
tions, proliferation, and intercellular adhesion possibly by 
controlling the structure of the matrix itself and thus influ- 
encing gene expression. Current investigations are in prog- 
ress to examine additional periods of development and to 
determine the pattern of synthesis of this important ECM 
component. 
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